Palliative techniques for hepatic cancer

Surgical Oncology Clinics of North America

Volumn 13, Issue 3, 2004, Pages 505-516

  Ruan, Daniel T ^a   Warren, Robert S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Francisco CA 94143 1932 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; CISPLATIN; DOXORUBICIN; ENBUCRILATE; EPIRUBICIN; FLOXURIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IODINATED POPPYSEED OIL; IODINE DERIVATIVE; IRINOTECAN; MITOMYCIN; OCTREOTIDE; OXALIPLATIN;

ABDOMINAL PAIN; ARTIFICIAL EMBOLISM; BLEEDING; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; CRYOTHERAPY; DIARRHEA; DUODENITIS; FEVER; GALLBLADDER; GASTRITIS; HEPATIC ARTERY; HEPATORENAL SYNDROME; HUMAN; HYPOTHERMIA; ISCHEMIA; LIVER ABSCESS; LIVER CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRCULATION; LIVER FAILURE; LIVER METASTASIS; META ANALYSIS; MYOGLOBINURIA; NEUROENDOCRINE TUMOR; PANCREATITIS; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; REVIEW; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MALE; PAIN MEASUREMENT; PALLIATIVE CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TERMINALLY ILL; TREATMENT OUTCOME;

EID: 3242678070     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2004.04.003     Document Type: Review

References (51)

1. Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Castagnetta L.A. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci. 963:2002;12-20
2. Zhou X.-D., Tang Z.-Y., Yang B.-H., Lin Z.-Y., Ma Z.-C., Ye S.-L., et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 91:(8):2001;1479-1486
3. American Cancer Society. Cancer facts & figures 2003. National Home Office: American Cancer Society Inc, Atlanta, GA; 2003. p. 4.
4. Taylor I., Mullee M.A., Campbell M.J. Prognostic index for the development of liver metastases in patients with colorectal cancer. Br J Surg. 77:(5):1990;499-501
5. Steele G. Jr., Ravikumar T.S. Resection of hepatic metastases form colorectal cancer: biologic perspectives. Ann Surg. 210:(2):1989;127-138
6. Norton J.A., Warren R.S., Kelly M.G., Zuraek M.B., Jensen R.T. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 134:2003;1057-1065
7. Rougier P., Mitry E. Chemotherapy in the treatment of neuroendocrine malignant tumors. Digestion. 62:(Suppl 1):2000;73-78
8. Breedis C., Young G. The blood supply of neoplasms in the liver. Am J Pathol. 30:1954;969-985
9. Simonetti R.G., Liberati A., Angiolini C., Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol. 8:1997;117-136
10. Trevisani F., De Notariis S., Rossi C., Bernardi M. Randomized controlled trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? J Clin Gastroent. 32:2001;383-389
11. Geschwind J.H., Ramsey D.E., Choti M.A., Thuluvath P.J., Huncharek M.S. Chemoembolization of hepatocellular carcinoma: results of metaanalysis. Am J Clin Oncol. 26:(4):2003;344-349
12. Llovet J.M., Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 37:2003;429-442
13. Huo T.I., Huang Y.H., Wu J.C., Chiang J.H., Lee P.C., Chang F.Y., et al. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol. 14:(11):2003;1648-1653
14. Hajarizadeh H., Ivancev K., Mueller C.R., Fletcher W.S., Woltering E.A. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg. 163:(5):1992;479-483
15. Ruszniewski P., Rougier P., Roche A., Legmann P., Sibert A., Hochlaf S., et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors: a prospective phase II study in 24 patients. Cancer. 71:1993;2624-2630
16. Therasse E., Breittmayer F., Roche A., De Baere T., Indushekar S., Ducreux M., et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology. 189:1993;541-547
17. Perry L.J., Stuart K., Stokes K.R., Clouse M.E. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery. 116:(6):1994;1111-1116
18. Drougas J.G., Anthony L.B., Blair T.K., Lopez R.R., Wright J.K. Jr., Chapman W.C., et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg. 175:(5):1998;408-412
19. Brown K.T., Koh B.Y., Brody L.A., Getrajdman G.I., Susman J., Fong Y., et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol. 10:(4):1999;397-403
20. Kim Y.H., Ajani J.A., Carrasco C.H., Dumas P., Richli W., Lawrence D., et al. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Invest. 17:(7):1999;474-478
21. Yao K.A., Talamonti M.S., Nemcek A., Angelos P., Chrisman H., Skarda J., et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 130:2001;677-685
22. Loewe C., Schindl M., Cejna M., Niederle B., Lammer J., Thurnher S. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol. 180:(5):2003;1379-1384
23. Kress O., Wagner H.-J., Wied M., Klose K.J., Arnold R., Alfke H. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - A retrospective single-center analysis. Digestion. 68:2003;94-101
24. Tellez C., Benson A.B. III, Lyster M.T., Talamonti M., Shaw J., Braun M.A., et al. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 82:1998;1250-1259
25. Andrews J.C., Walker S.C., Ackermann R.J., Cotton L.A., Ensminger W.D., Shapiro B. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nuc Med. 35:1994;1637-1644
26. Maini C.L., Scelsa M.G., Fiumara C., Tofani A., Sciuto R., Tipaldi L., et al. Superselective intra-arterial radioembolic therapy with I-131 lipiodol in hepatocellular carcinoma. Clin Nucl Med. 21:(3):1996;221-226
27. Herba M.J., Thirlwell M.P. Radioembolization for hepatic metastases. Semin Oncol. 29:2002;152-159
28. Ensminger W.D., Gyves J.W. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol. 10:(2):1983;176-182
29. Grage T.B., Vassilopoulos P.P., Shingleton W.W., Jubert A.V., Elias E.G., Aust J.B., et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases form colorectal cancer: a central oncology group study. Surgery. 86:(4):1979;550-555
30. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: a randomized trial. Ann Intern Med. 107:1987;459-465
31. Chang A.E., Schneider P.D., Sugarbaker P.H., Simpson C., Culnane M., Steinberg S.M. A prospective randomized trial of regional versus systemic continuous 5-fluorodexyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 206:(6):1987;685-693
32. Hohn D.C., Stagg R.J., Friedman M.A., Hannigan J.F., Rayner A., Ignoffo R.J., et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the northern California oncology group trial. J Clin Onc. 7:(11):1989;1646-1654
33. Martin J.K. Jr., O'Connell M.J., Wieand H.S., Fitzgibbons R.J., Mailliard J.A., Rubin J., et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer: a randomized trial. Arch Surg. 125:1990;1022-1027
34. Wagman L.D., Kemeny M.M., Leong L., Terz J.J., Hill R., Beatty J.D., et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol. 8:(11):1990;1885-1893
35. Rougier P., Laplanche A., Huguier M., Hay J.M., Ollivier J.M., Escat J., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 10:(7):1992;1112-1118
36. Allen-Mersh T.G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 344:1994;1255-1260
37. Lorenz M., Muller H.H. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 18:(2):2000;243-254
38. Kerr D.J., McArdle C.S., Lederman J., Taylor I., Sherlock D.J., Schlag P.M., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomized trial. Lancet. 361:2003;368-373
39. Meta-analysis group in cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 88:1996;252-258
40. Harmantas A., Rotstein L.E., Langer B. Regional versus systemic therapy in the treatment of colorectal carcinoma metastatic to the liver: is there a survival difference? Meta-analysis of the published literature. Cancer. 78:1996;1639-1645
41. Baker D.E. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum. Rev Gastroenterol Disord. 3:(1):2003;31-38
42. Gonen M., Hummer A., Zeroudakis A., Sullivan D., Fong Y., Banerjee D., et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol. 21:(3):2003;406-412
43. Yoshikawa M., Saisho H., Ebara M., Iijima T., Iwama S., Endo F., et al. A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with lipiodol versus 4'-epdoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol. 33:(Suppl 1):1994;49-52
44. Lai Y.-C., Shih C.-Y., Jeng C.-M., Yang S.-S., Hu J.-T., Sung Y.-C., et al. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with tumor thrombosis of portal vein. World J Gastroenterol. 9:(12):2003;2666-2670
45. Itamoto T., Nakahara H., Tashiro H., Haruta N., Asahara T., Naito A., et al. Hepatic arterial infusion of 5-fluoruracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol. 80:2002;143-148
46. Ando E., Tanaka M., Yamashita F., Kuromatsu R., Yutani S., Fukumori K., et al. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus: analysis of 48 cases. Cancer. 95:2002;588-595
47. Sumi S., Yamashita F., Ando E., Tanaka M., Yano Y., Fukumori K., et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. Am J Roentgenol. 181:(5):2003;1327-1334
48. Erce C., Parks R.W. Interstitial ablative techniques for hepatic tumours. Br J Surg. 90:2003;272-289
49. Garcea G., Lloyd T.D., Aylott C., Maddern G., Berry D.P. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer. 39:2003;2150-2164
50. Seifert J.K., Cozzi P.J., Morris D.L. Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol. 14:1998;175-183
51. Curley S.A., Izzo F., Delrio P., et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Results in 123 patients. Ann Surg. 230:(1):1999;1-8